Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024)

Guided Therapeutics (GTHP) posted Dividends Paid - Common of $54824.0 for Q2 2024, down 16.04% sequentially from $65296.0 in Q1 2024.

Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024) Analysis & Trends

Guided Therapeutics has reported Dividends Paid - Common for 2 years, with the latest figure at $54824.0 in Q2 2024.

Quarterly Dividends Paid - Common changed N/A year-over-year to $54824.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $120120.0 (up 83.96% YoY) and the FY2023 annual result came in at $65296.0, down 45.64% from the prior year.
Dividends Paid - Common retreated to $54824.0 in Q2 2024 per GTHP's latest filing, from $65296.0 in the prior quarter.
Over five years, Dividends Paid - Common peaked at $65296.0 in Q1 2023 and troughed at $54824.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Div. Paid (Common) (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	1.10 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	337.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	908.00 Mn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	16.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-373.12 Mn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	61.40 Mn
10	Guided Therapeutics	21.24 Mn	21.23 Mn	-	-

Download Data